ALXN - Alexion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 523.97B
Enterprise Value 326.02B
Trailing P/E 54.71
Forward P/E 112.72
PEG Ratio (5 yr expected) 10.97
Price/Sales (ttm)6.75
Price/Book (mrq)2.69
Enterprise Value/Revenue 37.33
Enterprise Value/EBITDA 617.69

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 12.48%
Operating Margin (ttm)27.69%

Management Effectiveness

Return on Assets (ttm)4.58%
Return on Equity (ttm)5.04%

Income Statement

Revenue (ttm)3.55B
Revenue Per Share (ttm)15.86
Quarterly Revenue Growth (yoy)9.50%
Gross Profit (ttm)3.1B
EBITDA 1.47B
Net Income Avi to Common (ttm)443.3M
Diluted EPS (ttm)1.97
Quarterly Earnings Growth (yoy)-67.60%

Balance Sheet

Total Cash (mrq)1.48B
Total Cash Per Share (mrq)6.69
Total Debt (mrq)3.23B
Total Debt/Equity (mrq)36.33
Current Ratio (mrq)3.10
Book Value Per Share (mrq)40.01

Cash Flow Statement

Operating Cash Flow (ttm)1.12B
Levered Free Cash Flow (ttm)879.16M

Trading Information

Stock Price History

Beta 1.07
52-Week Change 3-4.35%
S&P500 52-Week Change 314.67%
52 Week High 3149.34
52 Week Low 396.18
50-Day Moving Average 3115.36
200-Day Moving Average 3119.67

Share Statistics

Avg Vol (3 month) 32.12M
Avg Vol (10 day) 31.42M
Shares Outstanding 5222.36M
Float 219.63M
% Held by Insiders 10.64%
% Held by Institutions 196.90%
Shares Short 34.79M
Short Ratio 31.91
Short % of Float 32.52%
Shares Short (prior month) 35.23M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3May 23, 2011